Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VVOS compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name
VVOS
Vivos Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SYK
Stryker Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
VVOS
Vivos Therapeutics, Inc.
vs
SYK
Stryker Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
VVOS
Vivos Therapeutics, Inc.
Change
0.11
▼
−2.03%
Mkt cap
$2.3M
Revenue
$5M
Q2 FY26
Revenue
$17M
FY25
SYK
Stryker Corp
Change
305.77
▼
−0.34%
Regular session
Nov 3 '26
Mkt cap
$116.8B
Revenue
$6.5B
Q3 FY26
Revenue
$25.1B
FY25
vs
Compare
Regular session
Nov 3 '26
VVOS
Vivos Therapeutics, Inc.
vs
SYK
Stryker Corp
0.11
▼
−2.03%
Price
305.77
▼
−0.34%
$2.3M
Mkt cap
$116.8B
Q2 FY26
$5M
Revenue
$6.5B
Q3 FY26
FY25
$17M
Revenue
$25.1B
FY25
Change
Change
VVOS
0.11
▼
−2.03%
vs
SYK
305.77
▼
−0.34%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VVOS: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VVOS, solid
SYK, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VVOS
0
None
Shared
0
No disclosed counterparties: VVOS.
Only SYK
1
UFPT
UFP Technologies
supplier
Role chip = supplier or customer
Source: SEC EDGAR